{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:57:03Z","timestamp":1791910623564,"version":"4.3.4"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antipsychotics carry substantial risk in older adults, yet their use among community-dwelling outpatients remains insufficiently characterized in Saudi Arabia, where most prior work examined potentially inappropriate medications broadly or within psychiatric services. This study assessed patterns and appropriateness of antipsychotic prescribing and examined factors associated with prescribing without a documented qualifying indication among community-dwelling older adults across outpatient specialties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cross-sectional study of patients aged 65 or older with a qualifying outpatient antipsychotic dispensing at King Fahad Hospital of the University, Saudi Arabia, from January 2019 to May 2023. The index date was the first qualifying antipsychotic dispensing. A criteria-based algorithm classified each patient\u2019s prescribing appropriateness using FDA-approved indications, American Psychiatric Association guidelines, and the 2023 AGS Beers Criteria. Multivariable logistic regression identified factors associated with prescribing without a documented qualifying indication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 394 patients, clearly appropriate prescribing was identified in 16.0%, while dementia- or delirium-related prescribing was classified as high-risk\/context-dependent in 18.8%. Documented off-label prescribing was identified in 11.2%, 48.0% had no documented qualifying indication, and 6.1% had no diagnosis recorded within the ascertainment window. The latter group was excluded from comparative analyses. In the regression sample (n = 370), prescribing without a documented qualifying indication was more likely when the index antipsychotic was prescribed by medical or primary care (AOR 4.43, 95% CI 2.00 to 9.81; p &amp;lt; 0.001), neurology (AOR 2.42, 95% CI 1.27 to 4.63; p = 0.007), or other departments (AOR 3.16, 95% CI 1.16 to 8.63; p = 0.025) than by psychiatry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Prescribing without a documented qualifying indication was common outside psychiatry, but the absence of a qualifying diagnosis in the records does not confirm inappropriate prescribing. Systematic indication documentation, medication review, and targeted stewardship may improve prescribing quality in older adults.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1949586","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:48:08Z","timestamp":1790660888000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Patterns and appropriateness of antipsychotic prescribing in community-dwelling older adults: a retrospective study"],"prefix":"10.3389","volume":"17","author":[{"given":"Khalid A.","family":"Alamer","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Alsugeir","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz M.","family":"Alotaibi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Khalil","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, College of Pharmacy, Purdue University","place":["West Lafayette, IN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed J.","family":"Alfardan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra A.","family":"Alrashed","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad S.","family":"Alghareeb","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Alsultan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faten","family":"Alhomoud","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah Kais","family":"Alhomoud","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser A.","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Qassim University","place":["Qassim, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader R.","family":"Alzenaidy","sequence":"additional","affiliation":[{"name":"Saudi Food and Drug Authority","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef Saeed","family":"Alqarni","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Keshk","sequence":"additional","affiliation":[{"name":"Pharmacy Practice Department, College of Pharmacy, Purdue University","place":["West Lafayette, IN, United States"]},{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Mansoura University","place":["Mansoura, Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American geriatrics society 2023 updated AGS beers criteria for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J. Am. Geriatrics Soc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.sapharm.2020.10.010","article-title":"Reducing anticholinergic medication exposure among older adults using consumer technology: protocol for a randomized clinical trial","volume":"17","author":"Abebe","year":"2021","journal-title":"Res. Soc. Adm. Pharm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.sjbs.2016.05.006","article-title":"Potentially inappropriate medications prescribed for elderly patients through family physicians","volume":"24","author":"Al Odhayani","year":"2017","journal-title":"Saudi J. Biol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"102015","DOI":"10.1016\/j.jsps.2024.102015","article-title":"Use of potentially inappropriate medication for elderly patients in tertiary care hospital of Riyadh, Saudi Arabia","volume":"32","author":"Alanazi","year":"2024","journal-title":"Saudi Pharm. J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2147\/NDT.S100405","article-title":"Patterns of psychotropic medication use in inpatient and outpatient psychiatric settings in Saudi Arabia","volume":"12","author":"Alosaimi","year":"2016","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/healthcare10081440","article-title":"Potentially inappropriate medications among elderly with frailty in a tertiary care academic medical centre in Saudi Arabia","volume":"10","author":"Alsaad","year":"2022","journal-title":"Healthcare"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.3390\/healthcare13212705","article-title":"Exploring medication errors with antipsychotics in Saudi Arabia: insights from a nationwide analysis","volume":"13","author":"Alshehri","year":"2025","journal-title":"Healthcare"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1534828","DOI":"10.3389\/fmed.2025.1534828","article-title":"Potentially inappropriate medications use among the older patients diagnosed with psychiatric diseases in Saudi Arabia: a cross-sectional study","volume":"12","author":"Alsultan","year":"2025","journal-title":"Front. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/13607863.2017.1401583","article-title":"Off-label use of antipsychotics and associated factors in community living older adults","volume":"23","author":"Bakouni","year":"2019","journal-title":"Aging and Ment. Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e47841","DOI":"10.2196\/47841","article-title":"Errors, omissions, and offenses in the health record of mental health care patients: results from a nationwide survey in Sweden","volume":"25","author":"B\u00e4rk\u00e5s","year":"2023","journal-title":"J. Med. Internet Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.3390\/jcm15114359","article-title":"Advanced drug delivery strategies in geriatric patients with polypharmacy: integrating pharmacokinetics, personalized medicine, and emerging technologies","volume":"15","author":"Bartusik-Aebisher","year":"2026","journal-title":"J. Clin. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e98275","DOI":"10.7759\/cureus.98275","article-title":"Antipsychotic misuse: a silent but growing public health hazard","volume":"17","author":"Bhardwaj","year":"2025","journal-title":"Cureus"},{"key":"B14","first-page":"17","article-title":"Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline","volume":"64","author":"Bjerre","year":"2018","journal-title":"Can. Fam. Physician"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1001\/archinte.165.11.1280","article-title":"The quality of antipsychotic drug prescribing in nursing homes","volume":"165","author":"Briesacher","year":"2005","journal-title":"Archives Intern. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/jac5.1682","article-title":"Deprescribing anticholinergics in primary care older adults: experience from two models and impact on a continuous measure of exposure","volume":"5","author":"Campbell","year":"2022","journal-title":"J. Am. Coll. Clin. Pharm."},{"key":"B17","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1186\/s13063-024-08618-4","article-title":"Deprescribing anticholinergics to preserve brain health: reducing the risk of dementia through deprescribing (R2D2): study protocol for a randomized clinical trial","volume":"25","author":"Campbell","year":"2024","journal-title":"Trials"},{"key":"B18","doi-asserted-by":"publisher","first-page":"20451253231195274","DOI":"10.1177\/20451253231195274","article-title":"Managing medical and psychiatric multimorbidity in older patients","volume":"13","author":"Carlson","year":"2023","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","article-title":"Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends","volume":"21","author":"Carton","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"B20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.18773\/austprescr.2025.030","article-title":"Potentially inappropriate medicines for older people: consensus-based lists","volume":"48","author":"Choo","year":"2025","journal-title":"Aust. Prescr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"105454","DOI":"10.1016\/j.neubiorev.2023.105454","article-title":"An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs","volume":"155","author":"Chow","year":"2023","journal-title":"Neurosci. and Biobehav. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.18773\/austprescr.2021.011","article-title":"Caution with olanzapine use in dementia","volume":"44","author":"Coles","year":"2021","journal-title":"Aust. Prescr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/bjp.2026.10580","article-title":"The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus","author":"Goldberg","year":"2026","journal-title":"Br. J. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/ageing\/afaa122","article-title":"The burden of psychotropic and anticholinergic medicines use in care homes: population-based analysis in 147 care homes","volume":"50","author":"Grill","year":"2021","journal-title":"Age Ageing"},{"key":"B25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1192\/bja.2018.2","article-title":"Deprescribing antipsychotics: a guide for clinicians","volume":"24","author":"Gupta","year":"2018","journal-title":"BJPsych Adv."},{"key":"B26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/PROM.S42735","article-title":"Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies","volume":"5","author":"Haddad","year":"2014","journal-title":"Patient Relat. Outcome Meas."},{"key":"B27","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1186\/s12877-022-03235-9","article-title":"Anti-cholinergic drug burden in patients with dementia increases after hospital admission: a multicentre cross-sectional study","volume":"22","author":"Hook","year":"2022","journal-title":"BMC Geriatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3390\/healthcare11142003","article-title":"Potentially inappropriate medications in older adults\u2014Prevalence, trends and associated factors: a cross-sectional study in Saudi Arabia","volume":"11","author":"Jabri","year":"2023","journal-title":"Healthcare"},{"key":"B29","doi-asserted-by":"publisher","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"Bmj"},{"key":"B30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3122\/jabfm.2018.01.170230","article-title":"Primary care physician perspectives about antipsychotics and other medications for symptoms of dementia","volume":"31","author":"Kerns","year":"2018","journal-title":"J. Am. Board Fam. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/08039488.2026.2631597","article-title":"Characteristics and predictors of antipsychotic medication off-label use among community-dwelling older people","volume":"80","author":"Majuri","year":"2026","journal-title":"Nordic J. Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/pharma3020013","article-title":"Adverse drug reactions in multimorbid older people exposed to polypharmacy: epidemiology and prevention","volume":"3","author":"McGettigan","year":"2024","journal-title":"Pharmacoepidemiology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2165\/11632030-000000000-00000","article-title":"Off-label use of atypical antipsychotics: cause for concern?","volume":"26","author":"McKean","year":"2012","journal-title":"CNS Drugs"},{"key":"B34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40120-020-00188-2","article-title":"Potentially inappropriate medications in a psychogeriatric inpatient ward: an audit based on beers criteria","volume":"9","author":"Moebs","year":"2020","journal-title":"Neurology Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e076268","DOI":"10.1136\/bmj-2023-076268","article-title":"Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study","volume":"385","author":"Mok","year":"2024","journal-title":"Bmj"},{"key":"B3","first-page":"5214","article-title":"Anticholinergic effects of oral antipsychotic drugs of typicals versus atypicals over medium-and long-term: systematic review and meta-analyisis","volume-title":"Curr. Med. Chem.","author":"Ozbilen","year":"2012"},{"key":"B36","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1176\/appi.ajp.2015.173501","article-title":"The American psychiatric association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia","volume":"173","author":"Reus","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40266-022-00992-5","article-title":"Implications of adverse outcomes associated with antipsychotics in older patients with dementia: a 2011\u20132022 update","volume":"40","author":"Rogowska","year":"2023","journal-title":"Drugs Aging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s41999-019-00162-8","article-title":"EuGMS task and finish group on fall-risk-increasing drugs (FRIDs): position on knowledge dissemination, management, and future research","volume":"10","author":"Seppala","year":"2019","journal-title":"Eur. Geriatr. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S2215-0366(25)00261-5","article-title":"Antipsychotic prescriptions in people with dementia in primary care: a cohort study investigating adherence of dose and duration to UK clinical guidelines","volume":"12","author":"Smith","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12603-009-0237-0","article-title":"Contribution of drug related problems to hospital admission in the elderly","volume":"14","author":"Somers","year":"2010","journal-title":"J. Nutr. Health Aging"},{"key":"B41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","article-title":"Appropriate prescribing in elderly people: how well can it be measured and optimised?","volume":"370","author":"Spinewine","year":"2007","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s40266-025-01202-8","article-title":"Predictors and moderators of hospitalisation and mortality in people with dementia using antipsychotics: systematic review","volume":"42","author":"Tan","year":"2025","journal-title":"Drugs Aging"},{"key":"B43","unstructured":"Drugs@FDA: FDA-approved drugs [database]"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19585969.2025.2449833","article-title":"Antipsychotic off-label use in the 21st century: an enduring public health concern","volume":"27","author":"Verdoux","year":"2025","journal-title":"Dialogues Clin. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"B46","unstructured":"Anatomical therapeutic chemical (ATC) classification"},{"key":"B47","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s41999-021-00481-9","article-title":"Adverse drug reactions in older adults: a narrative review of the literature","volume":"12","author":"Zazzara","year":"2021","journal-title":"Eur. Geriatr. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1949586\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:48:10Z","timestamp":1790660890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1949586\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":47,"alternative-id":["10.3389\/fphar.2026.1949586"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1949586","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"article-number":"1949586"}}